This study aims to analyze the influence of profitability, sales growth, leverage, and company size on tax avoidance in pharmaceutical companies listed on the Indonesia Stock Exchange (IDX). The object analyzed in this study include pharmaceutical companies listed on the Indonesia Stock Exchange for the 2019–2024 period. The number of samples in this study consisted of 10 companies selected using purposive sampling techniques so that 60 observation data were obtained. Profitability is proxied by Return on Assets (ROA), sales growth is measured by sales growth ratio, leverage is represented by Debt to Total Assets Ratio (DAR), and company size is measured using the natural logarithm of total assets. Tax avoidance is measured using the Effective Tax Rate (ETR), while foreign transactions are used as a control variable.The research data was analyzed by applying multiple linear regression methods. The results of the study show that profitability, sales growth, leverage, and company size with foreign transactions as control variables simultaneously have a significant effect on tax avoidance. Partially, profitability, leverage, and company size have a significant negative effect on tax avoidance. Meanwhile, sales growth did not have a significant effect on tax avoidance. The findings of this study show that the internal characteristics of the company play an important role in influencing tax avoidance practices. The results of this study can be a consideration for company management, investors, and tax authorities in improving tax compliance and strengthening supervision of tax avoidance practices.